Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.
Hims & Hers Health, Inc. (HIMS) is a cutting-edge telehealth company, headquartered in San Francisco, California, that revolutionizes the way people access healthcare. Founded in 2013, the company provides a multi-specialty platform connecting consumers to licensed healthcare professionals, offering a seamless path to high-quality medical care for various conditions.
Hims & Hers Health, Inc. specializes in a broad range of wellness products and services. Their portfolio includes treatments for hair loss, sexual wellness products, skincare lines, and oral care solutions. The company also diversifies its offerings through an exclusive range of men's fashion items including sweaters, jackets, corduroy, sport coats, wool overcoats, leather boots, flannel shirts, caps, and candles. All products are conveniently available for purchase through their online platform.
The telehealth services provided by Hims & Hers are comprehensive, covering mental health, sexual health, dermatology, primary care, and more. This robust platform ensures consumers receive professional medical consultations from the comfort of their homes.
Hims & Hers Health, Inc. continues to innovate and expand its services to meet the evolving needs of its customers. Recent achievements include advancements in their telehealth technology, expanding partnerships with renowned medical professionals, and enhancing their product lines. The company is financially sound and continues to grow, reflecting positive market performance and consumer trust.
For the latest updates, financial reports, and company news, Hims & Hers Health remains a significant player in both the wellness product market and the telehealth industry.
Hims & Hers Health (NYSE: HIMS) has appointed Anja Manuel to its Board of Directors. Manuel brings vast experience in government relations, foreign policy, and regulatory issues, having co-founded the consulting firm Rice, Hadley, Gates & Manuel She is expected to help Hims & Hers innovate and expand personalized healthcare access. Manuel's background includes serving on boards of Ripple Labs and Overseas Shipping Group, and roles at the U.S. State Department, WilmerHale, and Salomon Brothers. She holds degrees from Stanford and Harvard Law School.
Hims & Hers Health, Inc. reported strong financial results for Q1 2024 with revenue of $278.2 million, up 46% YoY, net income of $11.1 million, and adjusted EBITDA of $32.3 million. Subscribers grew to 1.7 million, a 41% increase YoY. The company raised its full-year 2024 guidance to $1.20 billion to $1.23 billion in revenue and $120 million to $135 million in adjusted EBITDA.
FAQ
What is the current stock price of Hims & Hers Health (HIMS)?
What is the market cap of Hims & Hers Health (HIMS)?
What does Hims & Hers Health, Inc. do?
Where is Hims & Hers Health, Inc. based?
When was Hims & Hers Health, Inc. founded?
What types of products does Hims & Hers offer?
What medical services are available through Hims & Hers?
How can I purchase products from Hims & Hers?
How is Hims & Hers Health, Inc. performing financially?
What recent achievements has Hims & Hers Health, Inc. made?
Does Hims & Hers collaborate with healthcare professionals?
What makes Hims & Hers Health, Inc. unique?
